haloperidol has been researched along with Hyperglycemia in 22 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacovigilance survey of spontaneously reported adverse events in risperidone-treated patients, with reports of haloperidol-associated hyperglycemia used as a control." | 7.72 | Risperidone-associated diabetes mellitus: a pharmacovigilance study. ( Cross, JT; Doraiswamy, PM; Koller, EA; Schneider, BS, 2003) |
| " The authors' goal was to assess the effects of clozapine, olanzapine, risperidone, and haloperidol on glucose and cholesterol levels in hospitalized patients with schizophrenia or schizoaffective disorder during a randomized double-blind 14-week trial." | 5.10 | Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. ( Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, JP; Sheitman, B; Volavka, J, 2003) |
| "To report a case of fatal hyponatremia, marked hyperglycemia, and acute pancreatitis following simultaneous administration of paroxetine, fluphenazine, haloperidol and olanzapine." | 3.74 | Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy. ( Alfirevic, Z; Degoricija, V; Vucicevic, Z; Vukicevic-Badouin, D, 2007) |
| "Pharmacovigilance survey of spontaneously reported adverse events in risperidone-treated patients, with reports of haloperidol-associated hyperglycemia used as a control." | 3.72 | Risperidone-associated diabetes mellitus: a pharmacovigilance study. ( Cross, JT; Doraiswamy, PM; Koller, EA; Schneider, BS, 2003) |
| "To examine quantitatively the association between glucose intolerance including diabetes mellitus and the use of the atypical antipsychotics clozapine, olanzapine or risperidone, and to identify possible risk factors for the development of glucose intolerance during treatment with these drugs." | 3.71 | Glucose intolerance with atypical antipsychotics. ( Hägg, S; Hedenmalm, K; Mortimer, O; Spigset, O; Ståhl, M, 2002) |
| " To investigate further the issue the effects of alloxan-induced hyperglycemia on the incidence and severity of haloperidol-induced perioral movements were studied in the rat." | 3.68 | Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia. ( Sandyk, R, 1990) |
| "We present a case of hemichorea/hemiballism, a rare complication of hyperglycemia." | 1.51 | [Hemichorea/hemiballism a rare complication of hyperglycemia]. ( Kataja Knight, A; Magnusson, P; Sjöholm, Å; Tidehag, L, 2019) |
| "Hemichorea is a disorder characterized by abnormal, continuous, nonrhythmic, jerky, and distal movement involving one side of the body." | 1.43 | Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes. ( Al-Quliti, KW; Assaedi, ES, 2016) |
| "Three cases of hemichorea-hemiballismus (HC-HB) associated with nonketotic hyperglycemia were reported." | 1.35 | Hemichorea-hemiballismus associated with nonketotic hyperglycemia: a possible role of inflammation. ( Deng, BQ; Wang, JH; Wang, ZK; Wu, T; Zhang, P; Zhang, YW, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, S | 1 |
| Yamamura, R | 1 |
| Hashimoto, N | 1 |
| Okubo, R | 1 |
| Sawagashira, R | 1 |
| Ito, YM | 1 |
| Sato, N | 1 |
| Kusumi, I | 1 |
| Cho, HS | 1 |
| Hong, CT | 1 |
| Chan, L | 1 |
| Tidehag, L | 1 |
| Kataja Knight, A | 1 |
| Magnusson, P | 1 |
| Sjöholm, Å | 1 |
| Al-Quliti, KW | 1 |
| Assaedi, ES | 1 |
| Lin, CJ | 1 |
| Huang, P | 1 |
| Wang, JH | 1 |
| Wu, T | 1 |
| Deng, BQ | 1 |
| Zhang, YW | 1 |
| Zhang, P | 1 |
| Wang, ZK | 1 |
| Rock, W | 1 |
| Elias, M | 1 |
| Lev, A | 1 |
| Saliba, WR | 1 |
| Rafai, MA | 1 |
| Guynerane, M | 1 |
| Boulaajaj, FZ | 1 |
| Benchekroun, W | 1 |
| El Moutawakkil, B | 1 |
| Slassi, I | 1 |
| Kim, YD | 1 |
| Kim, JS | 1 |
| Song, IU | 1 |
| Lee, KS | 1 |
| Kim, YI | 1 |
| Hedenmalm, K | 1 |
| Hägg, S | 1 |
| Ståhl, M | 1 |
| Mortimer, O | 1 |
| Spigset, O | 1 |
| Lindenmayer, JP | 1 |
| Czobor, P | 1 |
| Volavka, J | 1 |
| Citrome, L | 1 |
| Sheitman, B | 1 |
| McEvoy, JP | 1 |
| Cooper, TB | 1 |
| Chakos, M | 1 |
| Lieberman, JA | 1 |
| Gupta, S | 1 |
| Koller, EA | 1 |
| Cross, JT | 1 |
| Doraiswamy, PM | 1 |
| Schneider, BS | 1 |
| Guha, P | 1 |
| Roy, K | 1 |
| Sanyal, D | 1 |
| Dasgupta, T | 1 |
| Bhattacharya, K | 1 |
| Wehrschuetz, M | 1 |
| Simbrunner, J | 1 |
| Enzinger, C | 1 |
| Ebner, F | 1 |
| Duncan, E | 1 |
| Dunlop, BW | 1 |
| Boshoven, W | 1 |
| Woolson, SL | 1 |
| Hamer, RM | 1 |
| Phillips, LS | 1 |
| Vucicevic, Z | 1 |
| Degoricija, V | 1 |
| Alfirevic, Z | 1 |
| Vukicevic-Badouin, D | 1 |
| Wannarka, GL | 1 |
| Fletcher, HP | 1 |
| Maickel, RP | 1 |
| Iwata, A | 1 |
| Koike, F | 1 |
| Arasaki, K | 1 |
| Tamaki, M | 1 |
| Oerlemans, WG | 1 |
| Moll, LC | 1 |
| Brambilla, F | 1 |
| Guastalla, A | 1 |
| Guerrini, A | 1 |
| Riggi, F | 1 |
| Rovere, C | 1 |
| Zanoboni, A | 1 |
| Zanoboni-Muciaccia, W | 1 |
| Sandyk, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness[NCT00661869] | 295 participants (Actual) | Interventional | 2006-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for haloperidol and Hyperglycemia
| Article | Year |
|---|---|
Hemichorea after hyperglycemia correction: A case report and a short review of hyperglycemia-related hemichorea at the euglycemic state.
Topics: Aged; Anti-Dyskinesia Agents; Diagnosis, Differential; Dyskinesias; Haloperidol; Humans; Hyperglycem | 2018 |
Safety in treating bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Diabetes Melli | 2003 |
2 trials available for haloperidol and Hyperglycemia
| Article | Year |
|---|---|
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Clozapine; Double-Bl | 2003 |
Olanzapine-induced obesity and diabetes in Indian patients: a prospective trial comparing olanzapine with typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Diabetes | 2005 |
18 other studies available for haloperidol and Hyperglycemia
| Article | Year |
|---|---|
The type rather than the daily dose or number of antipsychotics affects the incidence of hyperglycemic progression.
Topics: Adult; Antipsychotic Agents; Clozapine; Dibenzothiepins; Female; Haloperidol; Humans; Hyperglycemia; | 2022 |
[Hemichorea/hemiballism a rare complication of hyperglycemia].
Topics: Aged, 80 and over; Anti-Dyskinesia Agents; Basal Ganglia; Chorea; Dyskinesias; Female; Haloperidol; | 2019 |
Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes.
Topics: Anti-Dyskinesia Agents; Chorea; Diabetes Complications; Diabetes Mellitus; Female; Haloperidol; Huma | 2016 |
Delayed onset diabetic striatopathy: Hemichorea-hemiballism one month after a hyperglycemic episode.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Clonazepam; Diabetes Complications; Diagnosis, Differ | 2017 |
Hemichorea-hemiballismus associated with nonketotic hyperglycemia: a possible role of inflammation.
Topics: Aged, 80 and over; Anti-Dyskinesia Agents; Autoimmune Diseases of the Nervous System; Chorea; Corpus | 2009 |
Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
Topics: Adult; Antipsychotic Agents; Fatal Outcome; Haloperidol; Humans; Hyperglycemia; Male; Malignant Hype | 2009 |
[Left hemichorea revealing non ketotic hyperglycemia].
Topics: Brain; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine Antagonists; Female; Functional Laterality | 2010 |
Recurrence of hyperglycemic-induced chorea-ballismus after haloperidol withdrawal.
Topics: Aged, 80 and over; Antipsychotic Agents; Chorea; Haloperidol; Humans; Hyperglycemia; Male; Recurrenc | 2011 |
Glucose intolerance with atypical antipsychotics.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Chlor | 2002 |
Risperidone-associated diabetes mellitus: a pharmacovigilance study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2003 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combinati | 2007 |
Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Chlorpromazine; Cohort Studies; Female; Fluphe | 2007 |
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Edema; Fatal Outcome; Fluphenazine; Haloperidol; | 2007 |
Centrally mediated drug-induced hyperglycemia in mice.
Topics: Animals; Blood Glucose; Central Nervous System; Cyproheptadine; Haloperidol; Hyperglycemia; Male; Me | 1983 |
Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes.
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Blood-Brain Barrier; Chorea; Corpus Striatum; Cysteine; Diabe | 1999 |
Non-ketotic hyperglycemia in a young woman, presenting as hemiballism-hemichorea.
Topics: Acute Disease; Adult; Anti-Dyskinesia Agents; Brain; Chorea; Diagnosis, Differential; Dyskinesias; F | 1999 |
Glucose-insulin metabolism in chronic schizophrenia.
Topics: Adult; Blood Glucose; Diabetes Complications; Glucose; Glucose Tolerance Test; Haloperidol; Humans; | 1976 |
Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia.
Topics: Alloxan; Animals; Blood Glucose; Dyskinesia, Drug-Induced; Female; Haloperidol; Hyperglycemia; Rats; | 1990 |